Search Within

Omar Ibrahim Abdel-Wahab

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (37)
  2. Meeting Abstract (21)
  3. Research Letter (1)
Groups
  1. Center for Hematologic Malignancies (59)
  2. Department of Medicine (59)
  3. Epidemiology and Biostatistics (59)
  4. Executive Committee, Center for Hematologic Malignancies (59)
  5. GSK Faculty (59)
  6. Hematologic Malignancies, Division of (59)

More Groups

People
  1. Ross Levine (28)
  2. Martin Tallman (24)
  3. Mithat Gonen (21)
  4. Eytan Stein (13)
  5. Mikhail Roshal (11)
  6. Ahmet Dogan (10)

More People

Years
  1. 2024 (2)
  2. 2023 (11)
  3. 2022 (6)
  4. 2021 (5)
  5. 2020 (5)
  6. 2019 (4)

More Years

Publications
  1. Blood (20)
  2. Blood Advances (4)
  3. British Journal of Haematology (4)
  4. Leukemia (3)
  5. Leukemia Research (2)
  6. Nature (2)

More Publications

Publishers
  1. American Society of Hematology (24)
  2. Nature Publishing Group (10)
  3. John Wiley & Sons (4)
  4. Elsevier Science, Inc. (3)
  5. Massachusetts Medical Society (3)
  6. American Association for the Advancement of Science (2)

More Publishers

Results (59)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Single-cell spatial transcriptomics identifies lymphoid aggregates with location-specific alterations of adaptive immune cells in human MDS bone marrow
    Meeting Abstract

    Stanley, R.; Zhang, B.; Argyropoulos, K.; Gipson, B.; Weis, K.; Lewis, A. M.; Katsamakis, Z.; Zhao, K.; Snopkowski, C.; Zatzman, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy
    Journal Article

    Friedman, J. S.; Durham, B. H.; Reiner, A. S.; Yabe, M.; Petrova-Drus, K.; Dogan, A.; Pulitzer, M.; Busam, K. J.; Francis, J. H.; Rampal, R. K.; more...
    British Journal of Haematology (2024)

    Fulltext@MSK | Save
  • A phase 1b multi-center study of the FLT3 inhibitor gilteritinib in combination with the IDH1 inhibitor ivosidenib or the IDH2 inhibitor enasidenib for patients with relapsed or refractory acute myeloid leukemia who have co-occurring FLT3/IDH1 or FLT3/IDH2 mutations
    Meeting Abstract

    Stein, E. M.; Derkach, A.; Melamed, G.; Block, A.; Kim, J.; Georgieva, G.; Thompson, V.; Levine, R. L.; Intlekofer, A. M.; Abdel-Wahab, O.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • E7820, an anti-cancer sulfonamide, in combination with venetoclax in patients with splicing factor mutant myeloid malignancies: A phase II clinical trial
    Meeting Abstract

    Bewersdorf, J. P.; Chandhok, N. S.; Watts, J. M.; Derkach, A.; Abdel-Wahab, O.; Stein, E. M.; Taylor, J.
    Blood (2023)

    Fulltext@MSK | Save
  • Systematic evaluation of AML-associated antigens identifies anti-U5 SNRNP200 therapeutic antibodies for the treatment of acute myeloid leukemia
    Journal Article

    Knorr, K.; Rahman, J.; Erickson, C.; Wang, E.; Monetti, M.; Li, Z.; Ortiz-Pacheco, J.; Jones, A.; Lu, S. X.; Stanley, R. F.; more...
    Nature Cancer (2023)

    Fulltext@MSK | Save
  • E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies: A phase II clinical trial
    Research Letter

    Bewersdorf, J. P.; Stahl, M.; Taylor, J.; Mi, X.; Chandhok, N. S.; Watts, J.; Derkach, A.; Wysocki, M.; Lu, S. X.; Bourcier, J.; more...
    Leukemia (2023)

    Fulltext@MSK | Save
  • Outcomes after interruption of targeted therapy in patients with histiocytic neoplasms
    Journal Article

    Reiner, A. S.; Durham, B. H.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Lacouture, M. E.; Rotemberg, V.; Abdel-Wahab, O.; Panageas, K. S.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing
    Journal Article

    Ptashkin, R. N.; Ewalt, M. D.; Jayakumaran, G.; Kiecka, I.; Bowman, A. S.; Yao, J. J.; Casanova, J.; Lin, Y. T. D.; Petrova-Drus, K.; Mohanty, A. S.; more...
    Nature Communications (2023)

    Fulltext@MSK | Save
  • Vemurafenib and obinutuzumab as frontline therapy for hairy cell leukemia
    Journal Article

    Park, J. H.; Devlin, S.; Durham, B. H.; Winer, E. S.; Huntington, S.; von Keudell, G.; Vemuri, S.; Shukla, M.; Falco, V.; Cuello, B.; more...
    NEJM Evidence (2023)

    Fulltext@MSK | Save
  • Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia
    Journal Article

    McCarter, J. G. W.; Nemirovsky, D.; Famulare, C. A.; Farnoud, N.; Mohanty, A. S.; Stone-Molloy, Z. S.; Chervin, J.; Ball, B. J.; Epstein-Peterson, Z. D.; Arcila, M. E.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save